CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Boya Bio-pharmaceutical Group Co Ltd Company Snapshot
Boya Bio-pharmaceutical Group Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Boya Bio-pharmaceutical Group Co Ltd with three other companies in this sector in China: Beijing SL Pharmaceutical Co Ltd (2018 sales of 2.17 billion Chinese Renmimbi [US$306.96 million] of which 99% was Pharmaceuticals Industry), Shenzhen Kangtai Biological Products Co Ltd (2.02 billion Chinese Renmimbi [US$285.49 million] of which 100% was Biological products), and Tonghua Dongbao Medicines Company Limited (2.69 billion Chinese Renmimbi [US$380.64 million] of which 87% was Pharmaceutical).

Sales Analysis. Boya Bio-pharmaceutical Group Co Ltd reported sales of 2.45 billion Chinese Renmimbi (US$347.15 million) for the year ending December of 2018. This represents an increase of 67.8% versus 2017, when the company's sales were 1.46 billion Chinese Renmimbi. Sales at Boya Bio-pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 899%). Sales of Drug Distribution saw an increase that was more than double the company's growth rate: sales were up 551.4% in 2018, from 85.13 million Chinese Renmimbi to 554.55 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Boya Bio-pharmaceutical Group Co Ltd
  Stock Performance Chart for Boya Bio-pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 30.31
(Figures in Chinese Renmimbi)
1 Week -2.2%   13 Weeks -6.7%  
4 Weeks -5.5%   52 Weeks -5.0%  
 
Boya Bio-pharmaceutical Group Co Ltd Key Data:
  Ticker: 300294 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 2,451,304,842
(Year Ending Jan 2019).
Employees: 1,626
  Currency: Chinese Renmimbi Market Cap: 13,134,076,598
  Fiscal Yr Ends: December Shares Outstanding: 433,324,863
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.